A comorbidity index for mortality prediction in Chinese patients with ESRD receiving hemodialysis

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 3, 2014, Pages 513-519

  Chen, Jinn Yang ^a,b   Tsai, Shin Hung ^c   Chuang, Pei Hung ^d   Chang, Chia Hao ^a   Chuang, Chiao Lin ^a,b   Chen, Hui Ling ^e   Chen, Ping Ling ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CALIBRATION; CHARLSON COMORBIDITY INDEX; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PREVALENCE; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TREATMENT OUTCOME;

EID: 84896871233     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03100313     Document Type: Article

References (36)

1. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM: Influence of coexisting disease on survival on renal- replacement therapy. Lancet 341: 415-418, 1993
2. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI: Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survival. Am J Kidney Dis 26: 353-361, 1995
3. U.S. Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011
4. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108: 609-613, 2000
5. Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ: An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int 77: 141-151, 2010
6. Hwang SJ, Yang WC, Lin MY, Mau LW, Chen HC; Taiwan Society of Nephrology: Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: A national cohort study in Taiwan.Nephrol Dial Transplant 25: 2616-2624, 2010
7. Chae JW, Song CS, Kim H, Lee KB, Seo BS, Kim DI: Prediction of mortality in patients undergoing maintenance hemodialysis by Charlson Comorbidity Index using ICD-10 database. Nephron Clin Pract 117: c379-c384, 2011
8. Hou F, Jiang J, Chen J, Yu X, Zhou Q, Chen P, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Xie D, Liu J, Zhang P, Yang X, Zhang Y, Zhang Y, Liang X, Zhang Z, Lin Q, Yu Y, Wu S, Xu X: China collaborative study on dialysis: A multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis. BMC Nephrol 13: 94, 2012
9. Hayashino Y, Fukuhara S, Akiba T, Akizawa T, Asano Y, Saito A, Bragg-Gresham JL, Ramirez SP, Port FK, Kurokawa K: Diabetes, glycaemic control and mortality risk in patients on haemodialysis: The Japan Dialysis Outcomes and Practice Pattern Study. Diabetologia 50: 1170-1177, 2007
10. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF: All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 371: 2173-2182, 2008
11. Yang WC, Hwang SJ; Taiwan Society of Nephrology: Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: The impact of national health insurance. Nephrol Dial Transplant 23: 3977-3982, 2008
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383, 1987
13. vanManen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT; NECOSAD Study Group. Netherlands Cooperative Study on the Adequacy of Dialysis-2: How to adjust for comorbidity in survival studies in ESRD patients: A comparison of different indices. Am J Kidney Dis 40: 82-89, 2002
14. Chang CH, Lin JW, Wu LC, Lai MS, Chuang LM, Chan KA: Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Hepatology 55: 1462-1472, 2012
15. Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC: Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol 23: 2042-2049, 2012
16. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387, 1996
17. Harrell F: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis, New York, NY, Springer, 2001
18. Steyerberg E: Clinical Prediction Models: A Practical Approach to Development, Validation and Updating, New York, NY, Springer, 2009
19. O'Quigley J, Xu R, Stare J: Explained randomness in proportional hazards models. Stat Med 24: 479-489, 2005
20. Choodari-Oskooei B, Royston P, Parmar MK: A simulation study of predictive ability measures in a survival model I: Explained variation measures. Stat Med 31: 2627-2643, 2012
21. Pencina MJ, D'Agostino RB: Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 23: 2109-2123, 2004
22. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology 21: 128-138, 2010
23. Cook NR: Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve. Clin Chem 54: 17-23, 2008
24. Cook NR: Use andmisuse of the receiver operating characteristic curve in risk prediction. Circulation 115: 928-935, 2007
25. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, Jr., Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172; discussion 207-112, 2008
26. Luo JC, Leu HB, Huang KW, Huang CC, Hou MC, Lin HC, Lee FY, Lee SD: Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 183: E1345-E1351, 2011
27. Herzog CA, Littrell K, Arko C, Frederick PD, Blaney M: Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: A collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 116: 1465-1472, 2007
28. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349: 1269-1276, 1997
29. Wingard DL, Suarez L, Barrett-Connor E: The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol 117: 165-172, 1983
30. Villar E, Remontet L, Labeeuw M, Ecochard R: Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 18: 2125-2134, 2007
31. Carrero JJ, de Mutsert R, Axelsson J, Dekkers OM, Jager KJ, Boeschoten EW, Krediet RT, Dekker FW; NECOSAD Study Group: Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol Dial Transplant 26: 270-276, 2011
32. Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ: Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J AmSoc Nephrol 6: 1722-1730, 2011
33. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2: 89-99, 2007
34. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44: 115-119, 1993
35. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3: 505-521, 2008
36. Lindholm B, Davies S: End-stage renal disease: A new comorbidity index for estimating mortality risk in ESRD. Nat Rev Nephrol 6: 391-393, 2010